MuSK MG clinical trials at UC Davis

1 research study open to eligible people

Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18-75
Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-106.
Brea, California and other locations

Last updated: February 2025